BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Gastroenterology

The World Journal of Gastroenterology (WJG) is an academic journal that publishes review articles and articles describing original research (basic or clinical) in the fields of gastroenterology, hepatology, gastrointestinal surgery, and gastrointestinal endoscopy. With the aim of advancing knowledge in each of these fields, the WJG gives topical priority to related major diseases and their clinical management; frequently published disease topics are gastric cancer, colorectal cancer, hepatocellular carcinoma, pancreatic cancer, inflammatory bowel disease, irritable bowel syndrome, hepatitis C, hepatitis B, nonalcoholic fatty liver disease, and liver transplantation. All articles published in the WJG comply with the Code of Conduct of the Committee on Publication Ethics (COPE) and the requirements of Academic Rules and Norms. No restrictions are imposed on numbers of words, figures (color, B/W), tables or references for any articles published in the WJG, allowing authors to tell a whole story. The WJG readership audience is global, representing 221 countries and regions, with an average number of 55,000 visits to the online journal per day. 

We encourage gastroenterologists and hepatologists worldwide to submit manuscripts to the WJG describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJG are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJG’s acceptance rate: 35%. Submit here >>

2018 Published Issues
  • Andrzej S Tarnawski, DSc, MD, PhD, Professor, (E-mail:atarnawski@yahoo.com) Chief Gastroenterology, VA Long Beach Health Care System, University of California, Long Beach, CA 90822, United States
WJG is now abstracted and indexed in Science Citation Index Expanded (SCIE, also known as SciSearch®), Current Contents/Clinical Medicine, Journal Citation Reports, Index Medicus, MEDLINE, PubMed, PubMed Central, Scopus, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (CSTJ), and Superstar Journals Database.
Journal Metrics
The 2018 edition of Journal Citation Reports® cites the 2017 impact factor for WJG as 3.300 (5-year impact factor: 3.387), ranking WJG as 35 among 80 journals in gastroenterology and hepatology (quartile in category Q2). CiteScore (2017): 3.70.
1007-9327 (print) and 2219-2840 (online)
Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors 
Jian Li, Ming Wang, Bo Zhang, Xin Wu, Tian-Long Lin, Xiu-Feng Liu, Ye Zhou, Xin-Hua Zhang, Hao Xu, Li-Jing Shen, Jing Zou, Ping Lu, Dong Zhang, Wei-Jun Gu, Mei-Xia Zhang, Jian Pan, Hui Cao, Chinese Society of Surgeons for Gastrointestinal Stromal Tumor of the Chinese Medical Doctor Association 
World J Gastroenterol 24(46):5189-5202. Published online Dec 14, 2018. doi: 10.3748/wjg.v24.i46.5189
Liver transplantation for critically ill cirrhotic patients: Overview and pragmatic proposals 
Thierry Artzner, Baptiste Michard, Camille Besch, Eric Levesque, François Faitot 
World J Gastroenterol 24(46):5203-5214. Published online Dec 14, 2018. doi: 10.3748/wjg.v24.i46.5203
Management of sub-centimeter recurrent hepatocellular carcinoma after curative treatment: Current status and future 
Min Woo Lee, Hyo Keun Lim 
World J Gastroenterol 24(46):5215-5222. Published online Dec 14, 2018. doi: 10.3748/wjg.v24.i46.5215
Basic Study
Modulation of faecal metagenome in Crohn’s disease: Role of microRNAs as biomarkers 
María Rojas-Feria, Teresa Romero-García, Jose Ángel Fernández Caballero-Rico, Helena Pastor Ramírez, Marta Avilés-Recio, Manuel Castro-Fernandez, Natalia Chueca Porcuna, Manuel Romero-Gόmez, Federico García, Lourdes Grande, José A Del Campo 
World J Gastroenterol 24(46):5223-5233. Published online Dec 14, 2018. doi: 10.3748/wjg.v24.i46.5223
MicroRNA-15a - cell division cycle 42 signaling pathway in pathogenesis of pediatric inflammatory bowel disease 
Wen-Juan Tang, Kai-Yue Peng, Zi-Fei Tang, Yu-Huan Wang, Ai-Juan Xue, Ying Huang 
World J Gastroenterol 24(46):5234-5245. Published online Dec 14, 2018. doi: 10.3748/wjg.v24.i46.5234
Effect of photodynamic therapy with (17R,18R)-2-(1-hexyloxyethyl)-2-devinyl chlorine E6 trisodium salt on pancreatic cancer cells in vitro and in vivo 
Yu-Jie Shen, Jia Cao, Fang Sun, Xiao-Lei Cai, Ming-Ming Li, Nan-Nan Zheng, Chun-Ying Qu, Yi Zhang, Feng Shen, Min Zhou, Ying-Wei Chen, Lei-Ming Xu 
World J Gastroenterol 24(46):5246-5258. Published online Dec 14, 2018. doi: 10.3748/wjg.v24.i46.5246
Identification and prediction of novel non-coding and coding RNA-associated competing endogenous RNA networks in colorectal cancer 
Yu Liang, Cheng Zhang, Ming-Hui Ma, Dong-Qiu Dai 
World J Gastroenterol 24(46):5259-5270. Published online Dec 14, 2018. doi: 10.3748/wjg.v24.i46.5259
Retrospective Study
Relationship between response to lusutrombopag and splenic volume 
Haruki Uojima, Yoshitaka Arase, Norio Itokawa, Masanori Atsukawa, Takashi Satoh, Koji Miyazaki, Hisashi Hidaka, Ji Hyun Sung, Makoto Kako, Kota Tsuruya, Tatehiro Kagawa, Katsuhiko Iwakiri, Ryouichi Horie, Wasaburo Koizumi 
World J Gastroenterol 24(46):5271-5279. Published online Dec 14, 2018. doi: 10.3748/wjg.v24.i46.5271
Preliminary application of 3D-printed coplanar template for iodine-125 seed implantation therapy in patients with advanced pancreatic cancer 
Wei Huang, Jian Lu, Ke-Min Chen, Zhi-Yuan Wu, Qing-Bin Wang, Jing-Jing Liu, Ju Gong, Zhi-Jin Chen, Xiao-Yi Ding, Zhong-Min Wang 
World J Gastroenterol 24(46):5280-5287. Published online Dec 14, 2018. doi: 10.3748/wjg.v24.i46.5280
Observational Study
Loss of efficacy and safety of the switch from infliximab original to infliximab biosimilar (CT-P13) in patients with inflammatory bowel disease 
María Fernanda Guerra Veloz, Federico Argüelles-Arias, Luisa Castro Laria, Belén Maldonado Pérez, Antonio Benítez Roldan, Raúl Perea Amarillo, Vicente Merino Bohórquez, Miguel Angel Calleja, Ángel Caunedo Álvarez, Ángel Vilches Arenas 
World J Gastroenterol 24(46):5288-5296. Published online Dec 14, 2018. doi: 10.3748/wjg.v24.i46.5288